ESR1 and breast cancer: Similar pathology was observed in bilateral breast cancer, which showed invasive ductal carcinoma (IDC), categorized as estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-positive, with three involved lymph nodes in the right axilla and none in the left axilla.